Table:
begin	end	state
1	17	cytoplasmic
18	37	transmembrane
38	42	non-cytoplasmic
43	62	transmembrane
63	71	cytoplasmic
72	89	transmembrane
90	100	non-cytoplasmic
101	119	transmembrane
120	125	cytoplasmic
126	145	transmembrane
146	175	non-cytoplasmic
176	198	transmembrane
199	218	cytoplasmic
219	240	transmembrane
241	271	non-cytoplasmic
272	292	transmembrane
293	297	cytoplasmic
298	316	transmembrane
317	335	non-cytoplasmic
336	356	transmembrane
357	362	cytoplasmic
363	383	transmembrane
384	393	non-cytoplasmic
394	427	transmembrane
428	447	cytoplasmic
448	480	transmembrane
481	485	non-cytoplasmic
486	504	transmembrane
505	510	cytoplasmic
511	556	transmembrane
557	565	non-cytoplasmic
566	586	transmembrane
587	596	cytoplasmic
597	623	transmembrane
624	632	non-cytoplasmic
633	661	transmembrane
662	677	cytoplasmic


Input:
>199647 FitnessBrowser__MR1:199647
MSDSEQGLSANTSDWPKALFYSALIFSIFQIITAAFHPVSTQVLRATHVGFLLLVVFLSY
PAVGKSRPWQPLAWLLGLAGMATAAYQWIFEADLIQRSGELTDADMVMGIILIVLVFEAA
RRVMGWALPIICCIFLAYGLFGQYLPGDLMHRGYGVDQIINQLSFGTEGLYGTPTYVSAT
YIFLFILFGAFLEQAGMIRLFTDFAMGLFGHKLGGPAKVAVVSSALMGTITGSGVANVVT
TGQFTIPLMKRFGYRPAFAGGVEATSSMGSQIMPPIMGAVAFIMAETINVPFIEIAKAAL
LPALLYFCSVFWMVHLEAKRANLCGLPKDQCPDPWAAVKARWYLLIPLFILVYLLFSGRT
PLFSGMVGLALTSIVILGSAIVLRLPSNALRFAFWIALGVLCAGFFQMGIGVVFGVIAIL
VAICWFIKGGKDTLTICLHALVEGARHAVPVGIACALVGVIIGIVSLTGIASTFASYILA
VGQDNLFLSLVLTMITCLVLGMGIPTIPNYIITSSIAAPALLDLGVPLIVSHMFVFYFGI
MADLTPPVALACFAAAPIAKESGFKISLWAIRIAIAGFVIPFMAVYDPALMLQSDSWLAT
IYVLIKVTVAIGIWGVVFTGYLLQKLYLWERVIGFLAGGSLILATPLSDEIGFGLALLFI
VQHSLRARKLKRLAAQG

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server